USE OF EPITHELIAL MEMBRANE PROTEIN 2 [EMP2] TARGETING AGENTS IN TREATING LUNG DISORDERS
Technology
E-125-2018
Patent ID
E-125-2018-2-US-02
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
11890340
Publication Number
US-2021-0309737-A1
Application Number
17/051,678
IC
NIEHS
Date Filed
Date Issued